EFFECT OF CHEMOTHERAPY COMBINED WITH CAFFEINE FOR OSTEOSARCOMA

被引:41
作者
TSUCHIYA, H
YASUTAKE, H
YOKOGAWA, A
BABA, H
UEDA, Y
TOMITA, K
机构
[1] TONAMI GEN HOSP,DIV ORTHOPED SURG,TONAMI,TOYAMA 93913,JAPAN
[2] FUKUI MED SCH,DEPT ORTHOPED SURG,FUKUI 91011,JAPAN
[3] MUNSTER UNIV,GERHARD DOMAGK INST PATHOL,W-4400 MUNSTER,GERMANY
关键词
OSTEOSARCOMA; CHEMOTHERAPY; CAFFEINE; MARGINAL EXCISION;
D O I
10.1007/BF01211797
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nine patients with osteosarcoma were treated by chemotherapy combined with caffeine and surgery. All primary tumors showed complete histological response to preoperative chemotherapy consisting of three intraarterial infusions of cisplatin and caffeine without/with doxorubicin and two systemic high-dose methotrexate combined with vincristine. Limb-salvage surgery was performed in eight patients with marginal procedure, which led to the preservation of good limb function. Below-knee amputation was done in one patient with calcaneal osteosarcoma. There has been neither local recurrence nor lung metastasis in seven patients with conventional osteosarcoma during a median follow-up period of 28 months. Lung metastases leading to death were observed in one patient with small-cell osteosarcoma despite complete destruction of the primary tumor by preoperative chemotherapy. Chemotherapy combined with caffeine administration deserves further extensive and large-scale study in osteosarcoma.
引用
收藏
页码:567 / 569
页数:3
相关论文
共 20 条
[11]  
STINE KC, 1989, CANCER, V63, P848, DOI 10.1002/1097-0142(19890301)63:5<848::AID-CNCR2820630509>3.0.CO
[12]  
2-T
[13]  
TATEISHI A, 1989, NEW DEV LIMB SALVAGE, P189
[14]   CAFFEINE ENHANCEMENT OF THE EFFECT OF ANTICANCER AGENTS ON HUMAN SARCOMA-CELLS [J].
TOMITA, K ;
TSUCHIYA, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (01) :83-88
[15]   INTERMEDIATE RESULTS AND FUNCTIONAL-EVALUATION OF LIMB-SALVAGE SURGERY FOR OSTEO-SARCOMA - AN INTERGROUP STUDY IN JAPAN [J].
TOMITA, K ;
TSUCHIYA, H .
JOURNAL OF SURGICAL ONCOLOGY, 1989, 41 (02) :71-76
[16]  
TOMITA K, 1989, CLIN THER, V11, P43
[17]  
WINKLER K, 1990, CANCER, V66, P1703, DOI 10.1002/1097-0142(19901015)66:8<1703::AID-CNCR2820660809>3.0.CO
[18]  
2-V
[19]   NEOADJUVANT CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA - RESULTS OF A COOPERATIVE GERMAN-AUSTRIAN STUDY [J].
WINKLER, K ;
BERON, G ;
KOTZ, R ;
SALZERKUNTSCHIK, M ;
BECK, J ;
BECK, W ;
BRANDEIS, W ;
EBELL, W ;
ERTTMANN, R ;
GOBEL, U ;
HAVERS, W ;
HENZE, G ;
HINDERFELD, L ;
HOCKER, P ;
JOBKE, A ;
JURGENS, H ;
KABISCH, H ;
PREUSSER, P ;
PRINDULL, G ;
RAMACH, W ;
RITTER, J ;
SEKERA, J ;
TREUNER, J ;
WUST, G ;
LANDBECK, G .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :617-624
[20]  
WINKLER K, 1988, J CLIN ONCOL, V6, P639